Study of microphloors of sleevicular tract for dysbiotic disorders in children of various age
DOI:
https://doi.org/10.31548/dopovidi2018.05.004Abstract
In studying the quantitative and qualitative composition of the microflora of the gastrointestinal tract in children of all ages, dysbiotic disturbances were detected, and the most frequent was dysbiosis of the II degree - 48% of the number of persons with dysbiosis. Dysbiotic disorders were associated with the discovery of opportunistic strains of staphylococci and intestinal sticks. The studies on antibiotic resistance of staphylococci have shown a high level of resistance to ciprofloxacin - 60%, norfloxacin - 60%, and sensory strains were up to gentamicin and ampicillin - 80%. E. coli strains were resistant to norfloxacin - 90 and 92%, and ampicillin 60, 59%, and 59% and 59% for ceftriaxone and 58% and 59% for hematolytic and lactosonegative strains, respectively. In the study of phagosensitivity, integrated commercial drugs "Sektafag" and "Intesti-phage" were used, the effectiveness of which was 57 and 65% for staphylococci and 71, 58.1% for hemolytic and 81.2, 56.2% for lactosonegative strains of E. coli. .
Key words: staphylococcus, E. coli, antibiotic resistance, phagostimulation, dysbiosis, gastrointestinal tractReferences
Bekhtereva, M. K., & Ivanova V.V. (2014). Place of bacteriophages in the treatment of infectious diseases of the gastrointestinal tract.Consilium Medicum. Pediatrics, 2, 36‒40.
Bondarenko, V. М. (2013). Clinical effect and ways of rational use of therapeutic bacteriophages in median practice. Journal of Infectology, 3, 15‒19.
Bondarenko V. M. (2013). New horizons of bacteriophage therapy. Bulletin of the Orenburg Scientific Center, Ural Branch of the Russian Academy of Sciences (electronic journal), 4, 1‒12.
Geppe N. A., Gorelov A. V., & Dronov I. A. (2008). Problems of antibacterial therapy in intestinal infections in children. Honey. Council, 5, 22‒26.
Ilyenko, L. I., & Kholodova, I. N. (2008). Intestinal dysbacteriosis in children. General medicine, 2, 3–13.
Cutter E., & Sulakvelidze A. (2012). Bacteriophages. Biology and practical application: monograph. Moscow: The Scientific World.
Lyamin, A.V., Botkin E.A., & Zhestkov A.V. (2012). Method for identifying biofilms in medicine: opportunities and prospects. Klin, microbiol. anti-bacteria. Chemother, 1(14), 17‒22.
Tets, G.V., & Aklimenko K. L., (2006). Modern effect of antibiotics and deoxyribonucleases on bacteria. Antibiotics and chemotherapy, 53(51), 3‒6.
Topchiy N.V. (2015). Bacteriophages in the treatment of acute intestinal infections. Mediinsky Council, 8, 74‒81.
Chebotar I.V. (2012). Antibiotic resistance of biofilm bacteria. Wedge. Microbiol. antimicrobial. Chemotherm, 1(14), 51‒58.
Downloads
Published
Issue
Section
License
Relationship between right holders and users shall be governed by the terms of the license Creative Commons Attribution – non-commercial – Distribution On Same Conditions 4.0 international (CC BY-NC-SA 4.0):https://creativecommons.org/licenses/by-nc-sa/4.0/deed.uk
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).